Journal
PHYSIOLOGICAL GENOMICS
Volume 55, Issue 2, Pages 90-100Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physiolgenomics.00103.2022
Keywords
bone marrow mesenchymal stem cells; immune rejection; proliferation-inducing ligand; regulatory B cells; renal transplantation
Categories
Ask authors/readers for more resources
Bone marrow mesenchymal stem cells (BMSCs) play a crucial role in suppressing immune rejection in organ transplantation. This study aimed to investigate the effect and underlying mechanism of BMSCs on immune rejection in renal transplantation. The results demonstrated that BMSCs alleviated immune rejection in renal transplantation mice by promoting B cell activation and the production of IL-10+ regulatory B cells (Bregs) via the facilitation of a proliferation-inducing ligand (APRIL) phosphorylation. Overall, the findings suggest that BMSCs prevent renal transplant rejection through the induction of IL-10+ Bregs by facilitating APRIL phosphorylation.
Bone marrow mesenchymal stem cells (BMSCs) exert pivotal roles in suppressing immune rejection in organ transplantation. However, the function of BMSCs on immune rejection in renal transplantation remains unclear. This study aimed to evaluate the effect and underlying mechanism of BMSCs on immune rejection in renal transplantation. Following the establishment of the re-nal allograft mouse model, the isolated primary BMSCs were injected intravenously into the recipient mice. Enzyme-linked immu-nosorbent assay, flow cytometry, hematoxylin-eosin staining, and Western blot assays were conducted to investigate BMSCs' function in vivo and in vitro. Mechanistically, the underlying mechanism of BMSCs on immune rejection in renal transplantation was investigated in in vivo and in vitro models. Functionally, BMSCs alleviated the immune rejection in renal transplantation mice and facilitated B cell activation and the production of IL-10+ regulatory B cells (Bregs). Furthermore, the results of mechanism studies revealed that BMSCs induced the production of IL-10+ Bregs by facilitating a proliferation-inducing ligand (APRIL) phos-phorylation to enhance immunosuppression and repressed renal transplant rejection by promoting APRIL phosphorylation to induce IL-10+ Bregs. BMSCs prevent renal transplant rejection by facilitating APRIL phosphorylation to induce IL-10+ Bregs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available